| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |